Relationship between human immunodeficiency virus type 1 (HIV-1)-specific memory cytotoxic T lymphocytes and virus load after recent HIV-1 seroconversion

被引:17
作者
Connick, E
Schlichtemeier, RL
Purner, MB
Schneider, KM
Anderson, DM
MaWhinney, S
Campbell, TB
Kuritzkes, DR
Douglas, JM
Judson, FN
Schooley, RT
机构
[1] Univ Colorado, Hlth Sci Ctr, Dept Med, Div Infect Dis, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Prevent Med & Biometr, Denver, CO 80262 USA
[3] Denver Hlth & Hosp Author, Denver Dept Publ Hlth, Denver, CO USA
关键词
D O I
10.1086/324488
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human immunodeficiency virus type 1 (HIV-1)-specific memory, or precursor, cytotoxic T lymphocytes (CTL) in 14 subjects who had recently experienced seroconversion were evaluated with respect to virus set point, defined as plasma HIV-1 RNA level 6 months after seroconversion. Env-, Gag-, Pol-, and Nef-specific precursor CTL were detected in Cr-51-release assays, using antigen-stimulated peripheral blood mononuclear cells as effectors and B cell lines infected with HIV-1-vaccinia recombinants as targets. All subjects tested had precursor CTL specific to at least 2 HIV-1 antigens. Detection of Env- specific precursor CTL was associated with a high set point (P = .0221). The number of antigens recognized tended to be greater in subjects with higher set points (rho = .45621; P = .1171). Gag- specific precursor CTL frequency correlated inversely with set point (rho = -.8478; P = .0003). Two heterozygotes for a 32-bp deletion in CCR5 had the lowest set points (P = .0220) and highest Gag precursor CTL frequencies (P = .0128). These data suggest that host factors that restrict viral replication may be important determinants of the level of HIV-1-specific precursor CTL.
引用
收藏
页码:1465 / 1469
页数:5
相关论文
共 15 条
[1]   Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection [J].
Harrer, T ;
Harrer, E ;
Kalams, SA ;
Elbeik, T ;
Staprans, SI ;
Feinberg, MB ;
Cao, YZ ;
Ho, DD ;
Yilma, T ;
Caliendo, AM ;
Johnson, RP ;
Buchbinder, SP ;
Walker, BD .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (07) :585-592
[2]  
JOHNSON RP, 1991, J IMMUNOL, V147, P1512
[3]   Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection [J].
Kalams, SA ;
Buchbinder, SP ;
Rosenberg, ES ;
Billingsley, JM ;
Colbert, DS ;
Jones, NG ;
Shea, AK ;
Trocha, AK ;
Walker, BD .
JOURNAL OF VIROLOGY, 1999, 73 (08) :6715-6720
[4]   Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy [J].
Kalams, SA ;
Goulder, PJ ;
Shea, AK ;
Jones, NG ;
Trocha, AK ;
Ogg, GS ;
Walker, BD .
JOURNAL OF VIROLOGY, 1999, 73 (08) :6721-6728
[5]   KINETICS OF GAG-SPECIFIC CYTOTOXIC T-LYMPHOCYTE RESPONSES DURING THE CLINICAL COURSE OF HIV-1 INFECTION - A LONGITUDINAL ANALYSIS OF RAPID PROGRESSORS AND LONG-TERM ASYMPTOMATICS [J].
KLEIN, MR ;
VANBAALEN, CA ;
HOLWERDA, AM ;
KERKHOFGARDE, SR ;
BENDE, RJ ;
KEET, IPM ;
EEFTINCKSCHATTENKERK, JKM ;
OSTERHAUS, ADME ;
SCHUITEMAKER, H ;
MIEDEMA, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (04) :1365-1372
[6]   TEMPORAL ASSOCIATION OF CELLULAR IMMUNE-RESPONSES WITH THE INITIAL CONTROL OF VIREMIA IN PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SYNDROME [J].
KOUP, RA ;
SAFRIT, JT ;
CAO, YZ ;
ANDREWS, CA ;
MCLEOD, G ;
BORKOWSKY, W ;
FARTHING, C ;
HO, DD .
JOURNAL OF VIROLOGY, 1994, 68 (07) :4650-4655
[7]   A NOVEL METHOD FOR DETECTION AND EX-VIVO EXPANSION OF HIV TYPE 1-SPECIFIC CYTOLYTIC T-LYMPHOCYTES [J].
LUBAKI, MN ;
EGAN, MA ;
SILICIANO, RF ;
WEINHOLD, KJ ;
BOLLINGER, RC .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (11) :1427-1431
[8]   QUANTITATION OF HIV-1 RNA IN PLASMA PREDICTS OUTCOME AFTER SEROCONVERSION [J].
MELLORS, JW ;
KINGSLEY, LA ;
RINALDO, CR ;
TODD, JA ;
HOO, BS ;
KOKKA, RP ;
GUPTA, P .
ANNALS OF INTERNAL MEDICINE, 1995, 122 (08) :573-579
[9]   Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection [J].
Musey, L ;
Hughes, J ;
Schacker, T ;
Shea, T ;
Corey, L ;
McElrath, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (18) :1267-1274
[10]   Immune control of HIV-1 after early treatment of acute infection [J].
Rosenberg, ES ;
Altfeld, M ;
Poon, SH ;
Phillips, MN ;
Wilkes, BM ;
Eldridge, RL ;
Robbins, GK ;
D'Aquila, RT ;
Goulder, PJR ;
Walker, BD .
NATURE, 2000, 407 (6803) :523-526